Prosecution Insights
Last updated: August 06, 2026

Adler, Pollock & Sheehan, P.C.

10 pending office actions • 9 clients • 10 examiners • 10 art units • 0 of 10 (0%) have an AI response strategy ready

Quality Metrics (n=1375 apps, methodology: how we score firms)

87.6%
Allowance Rate
n=1375
+0.53σ
Allowance Rate (norm)
n=1375
2.9
OAs to Allowance
n=710
-0.51σ
OAs to Allow (norm)
n=710
954 days
Time to Allowance
n=710
+3.2pp
Interview Lift
n=1375
25.4%
RCE Rate
n=1375
1.7%
Appeal Rate
n=1375

Rejection Performance (% of received rejections ultimately overcome)

81.2%
§101 Overcome
n=69
74.2%
§102 Overcome
n=283
77.8%
§103 Overcome
n=410
81.8%
§112 Overcome
n=395

Specialization & Scale

A61K, A61P, A61B
Top CPC Subclasses
14%
Top-3 CPC Share
n=1375
3
Practitioners
n=1375
458.3
Apps / Practitioner
n=1375

Portfolio Summary

10
Total Pending OAs
5
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (80%)
0
Medium (0%)
2
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (10%)
§112 only2 (20%)
Multi-statute (no §101)7 (70%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
20% of docket
2
Mechanical / Eng
20% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ORTIZ, ADAM C 1 65.9% +34.8%
AFREMOVA, VERA 1 50.7% +29.2%
MACCRATE, NICOLE PAIGE 1 57.5% +23.6%
DILLON, DANIEL P 1 26.0% +30.3%
BOECKELMAN, JACOB A 1 36.1% +46.1%
WALTERS JR, ROBERT S 1 51.5% +50.5%
SMITH, DAVID E 1 85.1% +7.1%
TURK, NEIL N 1 50.9% +44.4%
KOLB, NATHANIEL J 1 62.5% +35.4%
BLUMEL, BENJAMIN P 1 70.7% +30.6%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17996489 TIME-RESOLVING HYPERSPECTRAL IMAGING SPECTROSCOPY SMITH, DAVID E 97d overdue
17906189 ANALYZER WITH AUTO-LOADER KOLB, NATHANIEL J 12d
19067759 NOVEL METHOD TO ALTER THE PROTEOME OF A DISEASED HEART BY INJECTION OF ECM PARTICLES PRODUCED FROM DECELLULARIZED 3D MICROTISSUES OF HUMAN MESENCHYMAL STEM CELLS AFREMOVA, VERA 26d
18957094 MEMBRANE COVERED ATTRACTANT POD MACCRATE, NICOLE PAIGE 29d
17723271 RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS BLUMEL, BENJAMIN P 35d
19248266 LEVELING INFANT BED ORTIZ, ADAM C
18566066 DURABLE FUNCTIONAL AND AESTHETIC LAMINATES DILLON, DANIEL P
18557561 DECELLULARIZED TISSUE HYDROGELS BOECKELMAN, JACOB A

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17933986 APPARATUS, METHOD, SYSTEM FOR THE DETERMINATION OF BLOODBORNE FACTORS INDICATIVE OF INFLAMMATION TURK, NEIL N 4d overdue
17906189 ANALYZER WITH AUTO-LOADER KOLB, NATHANIEL J 12d
19067759 NOVEL METHOD TO ALTER THE PROTEOME OF A DISEASED HEART BY INJECTION OF ECM PARTICLES PRODUCED FROM DECELLULARIZED 3D MICROTISSUES OF HUMAN MESENCHYMAL STEM CELLS AFREMOVA, VERA 26d
18957094 MEMBRANE COVERED ATTRACTANT POD MACCRATE, NICOLE PAIGE 29d
17723271 RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS BLUMEL, BENJAMIN P 35d
19248266 LEVELING INFANT BED ORTIZ, ADAM C
18566066 DURABLE FUNCTIONAL AND AESTHETIC LAMINATES DILLON, DANIEL P
18557561 DECELLULARIZED TISSUE HYDROGELS BOECKELMAN, JACOB A

Client Portfolio (9 clients)

Top Art Units

Art UnitApps
36731
16531
36421
17831
16551
17171
28811
17981
28961
16711

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19248266 LEVELING INFANT BED Kids2, LLC ORTIZ, ADAM C 3673 §102§103 Non-Final OA Pending Jun 24, 2025
19067759 NOVEL METHOD TO ALTER THE PROTEOME OF A DISEASED HEART BY INJECTION OF ECM PARTICLES PRODUCED FROM DECELLULARIZED 3D MICROTISSUES OF HUMAN MESENCHYMAL STEM CELLS Xm Therapeutics, Inc. AFREMOVA, VERA 1653 §102§103 Non-Final OA 26d Pending Feb 28, 2025
18957094 MEMBRANE COVERED ATTRACTANT POD American Insect Attractants LLC MACCRATE, NICOLE PAIGE 3642 §102§103§112 Final Rejection 29d Pending Nov 22, 2024
18566066 DURABLE FUNCTIONAL AND AESTHETIC LAMINATES BIXBY INTERNATIONAL CORPORATION DILLON, DANIEL P 1783 §103§112 Final Rejection Pending Nov 30, 2023
18557561 DECELLULARIZED TISSUE HYDROGELS The University of Nottingham BOECKELMAN, JACOB A 1655 §101§102§103§112 Final Rejection Pending Oct 26, 2023
18341067 DENTAL ALIGNER BIXBY INTERNATIONAL CORPORATION WALTERS JR, ROBERT S 1717 §112 Final Rejection Pending Jun 26, 2023
17996489 TIME-RESOLVING HYPERSPECTRAL IMAGING SPECTROSCOPY Research Instruments Corporation SMITH, DAVID E 2881 §102§103 Final Rejection 97d overdue Pending Oct 18, 2022
17933986 APPARATUS, METHOD, SYSTEM FOR THE DETERMINATION OF BLOODBORNE FACTORS INDICATIVE OF INFLAMMATION Alcor Scientific LLC TURK, NEIL N 1798 §112 Non-Final OA 4d overdue Pending Sep 21, 2022
17906189 ANALYZER WITH AUTO-LOADER Alcor Scientific LLC KOLB, NATHANIEL J 2896 §103§112 Non-Final OA 12d Pending Sep 12, 2022
17723271 RNA SEQUENCING TO DIAGNOSE SEPSIS AND OTHER DISEASES AND CONDITIONS Rhode Island Hospital BLUMEL, BENJAMIN P 1671 §102§103§112Other Non-Final OA 35d Pending Apr 18, 2022

Managing Adler, Pollock & Sheehan, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month